These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23045012)

  • 21. Metabolism of (-)-fenchone by CYP2A6 and CYP2B6 in human liver microsomes.
    Miyazawa M; Gyoubu K
    Xenobiotica; 2007 Feb; 37(2):194-204. PubMed ID: 17484521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytochrome P450 2B6 activity as measured by bupropion hydroxylation: effect of induction by rifampin and ethnicity.
    Loboz KK; Gross AS; Williams KM; Liauw WS; Day RO; Blievernicht JK; Zanger UM; McLachlan AJ
    Clin Pharmacol Ther; 2006 Jul; 80(1):75-84. PubMed ID: 16815319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of commonly used organic solvents on the kinetics of cytochrome P450 2B6- and 2C8-dependent activity in human liver microsomes.
    Vuppugalla R; Chang SY; Zhang H; Marathe PH; Rodrigues DA
    Drug Metab Dispos; 2007 Nov; 35(11):1990-5. PubMed ID: 17709370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the CYP2B6*6 allele on catalytic properties and inhibition of CYP2B6 in vitro: implication for the mechanism of reduced efavirenz metabolism and other CYP2B6 substrates in vivo.
    Xu C; Ogburn ET; Guo Y; Desta Z
    Drug Metab Dispos; 2012 Apr; 40(4):717-25. PubMed ID: 22232427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of the CYP2B6 component of 7-ethoxy-4-trifluoromethylcoumarin O-deethylation activity in human liver microsomes.
    Chang TK; Crespi CL; Waxman DJ
    Methods Mol Biol; 1998; 107():117-22. PubMed ID: 14577219
    [No Abstract]   [Full Text] [Related]  

  • 26. The monoterpenoids citral and geraniol are moderate inhibitors of CYP2B6 hydroxylase activity.
    Seo KA; Kim H; Ku HY; Ahn HJ; Park SJ; Bae SK; Shin JG; Liu KH
    Chem Biol Interact; 2008 Aug; 174(3):141-6. PubMed ID: 18611395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism of (+)-fenchone by CYP2A6 and CYP2B6 in human liver microsomes.
    Miyazawa M; Gyoubu K
    Biol Pharm Bull; 2006 Dec; 29(12):2354-8. PubMed ID: 17142962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of CYP2B6 component of 7-ethoxy-4-trifluoromethylcoumarin O-deethylation activity in human liver microsomes.
    Chang TK; Crespi CL; Waxman DJ
    Methods Mol Biol; 2006; 320():97-102. PubMed ID: 16719378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of bupropion metabolism by selegiline: mechanism-based inactivation of human CYP2B6 and characterization of glutathione and peptide adducts.
    Sridar C; Kenaan C; Hollenberg PF
    Drug Metab Dispos; 2012 Dec; 40(12):2256-66. PubMed ID: 22936314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profiles.
    Roy P; Yu LJ; Crespi CL; Waxman DJ
    Drug Metab Dispos; 1999 Jun; 27(6):655-66. PubMed ID: 10348794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytochrome P450 3A-mediated metabolism of buspirone in human liver microsomes.
    Zhu M; Zhao W; Jimenez H; Zhang D; Yeola S; Dai R; Vachharajani N; Mitroka J
    Drug Metab Dispos; 2005 Apr; 33(4):500-7. PubMed ID: 15640381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
    Miyazawa M; Shindo M; Shimada T
    Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative metabolism of BDE-99 by human liver microsomes: predominant role of CYP2B6.
    Erratico CA; Szeitz A; Bandiera SM
    Toxicol Sci; 2012 Oct; 129(2):280-92. PubMed ID: 22738989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation.
    Palovaara S; Pelkonen O; Uusitalo J; Lundgren S; Laine K
    Clin Pharmacol Ther; 2003 Oct; 74(4):326-33. PubMed ID: 14534519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereoselective metabolism of bupropion by cytochrome P4502B6 (CYP2B6) and human liver microsomes.
    Coles R; Kharasch ED
    Pharm Res; 2008 Jun; 25(6):1405-11. PubMed ID: 18219560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The in vitro metabolism of bupropion revisited: concentration dependent involvement of cytochrome P450 2C19.
    Chen Y; Liu HF; Liu L; Nguyen K; Jones EB; Fretland AJ
    Xenobiotica; 2010 Aug; 40(8):536-46. PubMed ID: 20528624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytochrome P450 2E1 is the primary enzyme responsible for low-dose carbon tetrachloride metabolism in human liver microsomes.
    Zangar RC; Benson JM; Burnett VL; Springer DL
    Chem Biol Interact; 2000 Mar; 125(3):233-43. PubMed ID: 10731522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CYP2B6 and CYP2C19 as the major enzymes responsible for the metabolism of selegiline, a drug used in the treatment of Parkinson's disease, as revealed from experiments with recombinant enzymes.
    Hidestrand M; Oscarson M; Salonen JS; Nyman L; Pelkonen O; Turpeinen M; Ingelman-Sundberg M
    Drug Metab Dispos; 2001 Nov; 29(11):1480-4. PubMed ID: 11602525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reevaluation of the microsomal metabolism of montelukast: major contribution by CYP2C8 at clinically relevant concentrations.
    Filppula AM; Laitila J; Neuvonen PJ; Backman JT
    Drug Metab Dispos; 2011 May; 39(5):904-11. PubMed ID: 21289076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased susceptibility of the cytochrome P450 2B6 variant K262R to inhibition by several clinically important drugs.
    Talakad JC; Kumar S; Halpert JR
    Drug Metab Dispos; 2009 Mar; 37(3):644-50. PubMed ID: 19074527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.